Spots Global Cancer Trial Database for biomarker analysis
Every month we try and update this database with for biomarker analysis cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| A Study of miRNA 371 in Patients With Germ Cell Tumors | NCT04435756 | Germ Cell Tumor Metachronous Ma... Seminoma Stage I Testicu... Stage IA Testic... Stage IB Testic... Stage IS Testic... | Biomarker Analy... Blood Product C... | 18 Years - | SWOG Cancer Research Network | |
| ANGIOPREDICT. ICORG 12-16, V3 | NCT01822444 | Advanced Colore... | Biomarker analy... | 18 Years - | Cancer Trials Ireland | |
| POA Retrospective Repository | NCT03326479 | Oncology Solid Tumor, Ad... | Caris Molecular... | 18 Years - | Caris Science, Inc. | |
| Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer | NCT00897338 | Breast Cancer | flow cytometry fluorescence ac... immunohistochem... immunologic tec... biomarker analy... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| ANGIOPREDICT. ICORG 12-16, V3 | NCT01822444 | Advanced Colore... | Biomarker analy... | 18 Years - | Cancer Trials Ireland | |
| Acute Exercise Intervention in Breast Cancer Survivors | NCT03779867 | Breast Carcinom... | Exercise Interv... Resting Biomarker Analy... Questionnaire A... | 18 Years - 75 Years | Fred Hutchinson Cancer Center | |
| Exosomal and Free Extracellular RNAs and Proteins as Predictive Biomarkers for HER2 Therapies in Breast Cancer | NCT01840306 | Breast Cancer HER2 Positive B... HER2 Negative B... | Biomarker Analy... | 18 Years - | Cancer Trials Ireland | |
| Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer | NCT05552001 | Triple Negative... Metastatic Brea... | Sacituzumab gov... | 18 Years - | UNICANCER | |
| Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer | NCT00897338 | Breast Cancer | flow cytometry fluorescence ac... immunohistochem... immunologic tec... biomarker analy... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer | NCT02204943 | Bone Metastatic... | Biomarker analy... Administration ... | 18 Years - | Duke University | |
| POA Prospective Repository | NCT03324841 | Solid Tumor, Ad... Oncology | Caris MI Profil... | 18 Years - | Caris Science, Inc. | |
| Identifying Circulating Breast Cancer Cells in Women With Metastatic Breast Cancer | NCT00897338 | Breast Cancer | flow cytometry fluorescence ac... immunohistochem... immunologic tec... biomarker analy... | 18 Years - | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| ANGIOPREDICT. ICORG 12-16, V3 | NCT01822444 | Advanced Colore... | Biomarker analy... | 18 Years - | Cancer Trials Ireland | |
| Lapatinib and Epirubicin in Treating Patients With Metastatic Breast Cancer. ICORG 06-30 | NCT00753207 | Breast Cancer | epirubicin hydr... lapatinib ditos... biomarker analy... immunohistochem... liquid chromato... mass spectromet... | 18 Years - 120 Years | Cancer Trials Ireland | |
| Pharmacodynamic Study of Radium-223 in Men With Bone Metastatic Castration-Resistant Prostate Cancer | NCT02204943 | Bone Metastatic... | Biomarker analy... Administration ... | 18 Years - | Duke University | |
| Blood and Tissue Study of Patients in NIH Protocol 08-C-0800 | NCT00923325 | Sarcomas | 2 Years - 99 Years | National Institutes of Health Clinical Center (CC) | ||
| Acute Exercise Intervention in Breast Cancer Survivors | NCT03779867 | Breast Carcinom... | Exercise Interv... Resting Biomarker Analy... Questionnaire A... | 18 Years - 75 Years | Fred Hutchinson Cancer Center | |
| Follow-up Evaluation Using CT Scans in Patients Who Have Been Treated For Metastatic Testicular Cancer | NCT00553371 | Testicular Germ... | biomarker analy... computed tomogr... | 18 Years - | National Cancer Institute (NCI) | |
| Throat and Other HPV-Related Cancers in Men: Identifying Them Early | NCT02897427 | Human Papilloma... | Biomarker Analy... Biospecimen Col... Ultrasonography | 50 Years - 64 Years | Baylor College of Medicine | |
| POA Retrospective Repository | NCT03326479 | Oncology Solid Tumor, Ad... | Caris Molecular... | 18 Years - | Caris Science, Inc. | |
| Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer | NCT05552001 | Triple Negative... Metastatic Brea... | Sacituzumab gov... | 18 Years - | UNICANCER | |
| MicroRNA as Markers in Testicular Cancer | NCT04914026 | Testicular Germ... Seminoma Non-Seminoma Te... Stage I Testicu... Stage II Testic... Stage III Testi... Stage IV Testic... Relapse Testicu... | Biomarker analy... | 18 Years - 70 Years | Haukeland University Hospital | |
| Acute Exercise Intervention in Breast Cancer Survivors | NCT03779867 | Breast Carcinom... | Exercise Interv... Resting Biomarker Analy... Questionnaire A... | 18 Years - 75 Years | Fred Hutchinson Cancer Center | |
| Blood and Tissue Study of Patients in NIH Protocol 08-C-0800 | NCT00923325 | Sarcomas | 2 Years - 99 Years | National Institutes of Health Clinical Center (CC) |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
